US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nuvalent, Inc.

96.66

-1.4000-1.43%

Post-market: 96.660.00000.00%16:34 EDT

Volume:482.66K

Turnover:46.65M

Market Cap:7.60B

PE:-16.52

High:98.70

Open:98.00

Low:95.72

Close:98.06

52wk High:113.02

52wk Low:55.54

Shares:78.62M

Float Shares:48.73M

Volume Ratio:0.79

T/O Rate:0.99%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.8522

EPS(LYR):-5.8522

ROE:-36.70%

ROA:-20.27%

PB:6.09

PE(LYR):-16.52

Loading ...

Overview Company News Filings

What's Going On With Royalty Pharma Stock Wednesday?

BRIEF-Nuvalent Files For Mixed Shelf Offering Size Not Disclosed - SEC Filing

Nuvalent Inc: Files for Mixed Shelf Offering; Size Not Disclosed - SEC Filing

THOMSON REUTERS

Nuvalent Inc. to Present at J.P. Morgan Healthcare Conference

Nuvalent Is Maintained at Overweight by JP Morgan

Nuvalent Inc : JP Morgan Cuts Target Price to $145 From $147

THOMSON REUTERS

How Investors Are Reacting To Royalty Pharma (RPRX) Expanding Oncology Royalties With Nuvalent Deal

Simply Wall St.

Royalty Pharma - Buys Low-Single Digit Royalty on Neladalkib and Zidesamtinib

THOMSON REUTERS

Royalty Pharma - Royalty Duration for Both Therapies Extends Through 2041 to 2042

THOMSON REUTERS

Royalty Pharma Acquires Royalty Interest in Nuvalent’s Neladalkib and Zidesamtinib for Up to $315 Million

Nuvalent Inc. Files Initial Statement of Beneficial Ownership for Director Ron Squarer

Nuvalent CFO Alexandra Balcom Reports Sale of Common Shares

Press Release: Nuvalent Appoints Ron Squarer to Board of Directors

Nuvalent (NUVL) Valuation After FDA Breakthrough Designation and Investor Optimism in Lung Cancer Franchise

Simply Wall St.

Nuvalent Chief Development Officer Darlene Noci Reports Sale of Common Shares

Nuvalent Director Matthew Shair Reports Sale of Common Shares

Director James E. Flynn Reports Sale of Nuvalent Inc. Common Shares

Nuvalent Closes Public Offering of Common Shares

MT Newswires Live

Nuvalent initiated with a Buy at Truist

J.P. Morgan Sticks to Its Buy Rating for Nuvalent (NUVL)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NUVL/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NUVL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NUVL\",,,,,undefined,":{"symbol":"NUVL","market":"US","secType":"STK","nameCN":"Nuvalent, Inc.","latestPrice":96.66,"timestamp":1774641600000,"preClose":98.06,"halted":0,"volume":482661,"hourTrading":{"tag":"盘后","latestPrice":96.66,"preClose":96.66,"latestTime":"16:34 EDT","volume":12305,"amount":1189370.22,"timestamp":1774643652680,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.014276973281664345,"floatShares":48726899,"shares":78617001,"eps":-5.852194,"marketStatus":"Market Closed","change":-1.4,"latestTime":"03-27 16:00:00 EDT","open":98,"high":98.695,"low":95.72,"amount":46648823.654249996,"amplitude":0.030339,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.852194,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"listingDate":1627531200000,"exchange":"NASDAQ","adjPreClose":98.06,"preHourTrading":{"tag":"盘前","latestPrice":98.02,"preClose":98.06,"latestTime":"08:49 EDT","volume":8,"amount":787.42004,"timestamp":1774615748247,"change":-0.04,"changeRate":-0.000408,"amplitude":0.00979},"postHourTrading":{"tag":"盘后","latestPrice":96.66,"preClose":96.66,"latestTime":"16:34 EDT","volume":12305,"amount":1189370.22,"timestamp":1774643652680,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7907711394813035,"impliedVol":0.4137,"impliedVolPercentile":0.2948},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NUVL\",,,,,undefined,":{"symbol":"NUVL","floatShares":48726899,"roa":"-20.27%","roe":"-36.70%","lyrEps":-5.852194,"volumeRatio":0.7907711394813035,"shares":78617001,"dividePrice":0,"high":98.695,"amplitude":0.030339,"preClose":98.06,"low":95.72,"week52Low":55.535,"pbRate":"6.09","week52High":113.015,"institutionHeld":0,"latestPrice":96.66,"eps":-5.852194,"divideRate":0,"volume":482661,"delay":0,"ttmEps":-5.852194,"open":98,"prevYearClose":100.59,"prevWeekClose":94.77,"prevMonthClose":101.95,"prevQuarterClose":100.59,"fiveDayClose":94.77,"twentyDayClose":101.95,"sixtyDayClose":100.38},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NUVL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-26","symbol":"NUVL","fiscalQuarterEnding":"2025/12","expectedEps":-1.48,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"pre","actualEps":-1.29},{"market":"US","date":"2025-10-30","symbol":"NUVL","fiscalQuarterEnding":"2025/09","expectedEps":-1.39,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1761796800000,"reportTimeType":"pre","actualEps":-1.7},{"market":"US","date":"2025-05-08","symbol":"NUVL","fiscalQuarterEnding":"2025/03","expectedEps":-1.14,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-1.18},{"market":"US","date":"2021-09-08","symbol":"NUVL","fiscalQuarterEnding":"2021/06","expectedEps":-0.21,"name":null,"time":"","type":"earning","dateTimestamp":1631073600000,"reportTimeType":"","actualEps":-3.17}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NUVL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NUVL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":18,"updateTime":1764043200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NUVL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NUVL","date":"2026-03-27","current":-16.516882,"percent":0.770979,"low":-69.351693,"twenty":-34.507969,"median":-24.160683,"eighty":-17.579848,"high":-6.26114,"avg":-25.825944,"sd":10.525741,"marketCap":7709183118},"quantilePoints":[{"date":"2021-07-30","current":-32.003439,"twenty":-32.354161,"median":-30.636831,"eighty":-29.270224,"marketCap":854491809},{"date":"2021-08-06","current":-39.893047,"twenty":-43.683429,"median":-39.621789,"eighty":-30.910153,"marketCap":1065144356},{"date":"2021-08-13","current":-40.471731,"twenty":-41.958227,"median":-39.504244,"eighty":-32.529523,"marketCap":1080595226},{"date":"2021-08-20","current":-48.862653,"twenty":-46.591318,"median":-40.471731,"eighty":-36.252451,"marketCap":1304632842},{"date":"2021-08-27","current":-62.732992,"twenty":-50.544455,"median":-43.437488,"eighty":-38.56569,"marketCap":1674970884},{"date":"2021-09-03","current":-68.881512,"twenty":-60.248267,"median":-45.860729,"eighty":-39.075655,"marketCap":1839136379},{"date":"2021-09-10","current":-65.348412,"twenty":-63.759706,"median":-47.741452,"eighty":-39.480734,"marketCap":1828513906},{"date":"2021-09-17","current":-62.94983,"twenty":-64.761708,"median":-50.860923,"eighty":-39.730292,"marketCap":1761399189},{"date":"2021-09-24","current":-39.44718,"twenty":-64.530478,"median":-49.278583,"eighty":-39.730292,"marketCap":1103771531},{"date":"2021-10-01","current":-41.63869,"twenty":-64.170784,"median":-47.714326,"eighty":-39.410891,"marketCap":1165092171},{"date":"2021-10-08","current":-31.371379,"twenty":-63.759706,"median":-45.860729,"eighty":-38.543989,"marketCap":877802556},{"date":"2021-10-15","current":-34.391176,"twenty":-63.187962,"median":-44.468269,"eighty":-35.519718,"marketCap":962299502},{"date":"2021-10-22","current":-34.529224,"twenty":-62.863095,"median":-42.812096,"eighty":-35.340256,"marketCap":966162219},{"date":"2021-10-29","current":-42.156369,"twenty":-62.364081,"median":-41.897529,"eighty":-36.171994,"marketCap":1179577362},{"date":"2021-11-05","current":-50.180402,"twenty":-61.727974,"median":-42.812096,"eighty":-36.430833,"marketCap":1404097818},{"date":"2021-11-12","current":-34.028754,"twenty":-60.644972,"median":-42.648165,"eighty":-36.184709,"marketCap":1212410461},{"date":"2021-11-19","current":-33.039467,"twenty":-58.433025,"median":-41.63869,"eighty":-35.340256,"marketCap":1177163164},{"date":"2021-11-26","current":-27.740684,"twenty":-57.008396,"median":-40.965706,"eighty":-34.418786,"marketCap":988372845},{"date":"2021-12-03","current":-27.063091,"twenty":-55.474121,"median":-40.006605,"eighty":-33.154505,"marketCap":964230860},{"date":"2021-12-10","current":-29.08232,"twenty":-53.340223,"median":-39.44718,"eighty":-32.23948,"marketCap":1036173974},{"date":"2021-12-17","current":-30.952478,"twenty":-52.342712,"median":-39.01578,"eighty":-31.220564,"marketCap":1102805851},{"date":"2021-12-23","current":-26.0467,"twenty":-51.940512,"median":-38.554839,"eighty":-29.461772,"marketCap":928017884},{"date":"2021-12-31","current":-25.802767,"twenty":-50.991433,"median":-38.204749,"eighty":-29.258494,"marketCap":919326769},{"date":"2022-01-07","current":-19.785735,"twenty":-50.180402,"median":-37.074482,"eighty":-28.635108,"marketCap":704945947},{"date":"2022-01-14","current":-17.210879,"twenty":-49.278583,"median":-36.755246,"eighty":-27.835548,"marketCap":613206406},{"date":"2022-01-21","current":-16.723012,"twenty":-48.945839,"median":-36.461894,"eighty":-27.290762,"marketCap":595824177},{"date":"2022-01-28","current":-17.590331,"twenty":-48.274083,"median":-36.023835,"eighty":-26.393628,"marketCap":626725917},{"date":"2022-02-04","current":-19.528249,"twenty":-47.81855,"median":-34.8916,"eighty":-26.000624,"marketCap":695771993},{"date":"2022-02-11","current":-24.325612,"twenty":-47.698051,"median":-34.304828,"eighty":-25.474811,"marketCap":866697243},{"date":"2022-02-18","current":-24.108782,"twenty":-47.445386,"median":-33.614657,"eighty":-24.726748,"marketCap":858971808},{"date":"2022-02-25","current":-21.018955,"twenty":-46.753363,"median":-32.880245,"eighty":-23.908215,"marketCap":748884359},{"date":"2022-03-04","current":-20.463328,"twenty":-46.073478,"median":-32.376852,"eighty":-22.116657,"marketCap":729087931},{"date":"2022-03-11","current":-21.005403,"twenty":-45.876805,"median":-31.765591,"eighty":-21.612527,"marketCap":748401519},{"date":"2022-03-18","current":-16.289352,"twenty":-45.336102,"median":-31.130443,"eighty":-21.013534,"marketCap":580373307},{"date":"2022-03-25","current":-17.102464,"twenty":-44.94676,"median":-29.461772,"eighty":-20.382017,"marketCap":609343688},{"date":"2022-04-01","current":-15.39984,"twenty":-44.68041,"median":-29.270224,"eighty":-19.994434,"marketCap":713597794},{"date":"2022-04-08","current":-13.710758,"twenty":-44.217879,"median":-29.08232,"eighty":-18.704295,"marketCap":635329113},{"date":"2022-04-14","current":-12.397028,"twenty":-43.553225,"median":-28.729971,"eighty":-18.145958,"marketCap":574453471},{"date":"2022-04-22","current":-11.343958,"twenty":-42.840121,"median":-28.228552,"eighty":-17.273218,"marketCap":525656330},{"date":"2022-04-29","current":-10.728799,"twenty":-42.680951,"median":-27.835548,"eighty":-17.086202,"marketCap":497151070},{"date":"2022-05-06","current":-10.926901,"twenty":-42.353087,"median":-27.38156,"eighty":-16.790771,"marketCap":506330730},{"date":"2022-05-13","current":-6.7688,"twenty":-41.949297,"median":-26.954676,"eighty":-16.549548,"marketCap":386512008},{"date":"2022-05-20","current":-6.819566,"twenty":-41.526351,"median":-26.487136,"eighty":-16.27309,"marketCap":389410848},{"date":"2022-05-27","current":-7.987184,"twenty":-41.200988,"median":-26.0467,"eighty":-15.742753,"marketCap":456084169},{"date":"2022-06-03","current":-7.775659,"twenty":-40.866911,"median":-26.033148,"eighty":-14.722122,"marketCap":444005669},{"date":"2022-06-10","current":-7.919496,"twenty":-40.401417,"median":-25.836647,"eighty":-13.721184,"marketCap":452219049},{"date":"2022-06-17","current":-8.477922,"twenty":-40.07474,"median":-25.545281,"eighty":-12.528401,"marketCap":484106290},{"date":"2022-06-24","current":-11.498499,"twenty":-39.893047,"median":-24.827032,"eighty":-12.282337,"marketCap":656587273},{"date":"2022-07-01","current":-11.464655,"twenty":-39.621789,"median":-24.09523,"eighty":-11.740163,"marketCap":654654713},{"date":"2022-07-08","current":-15.39902,"twenty":-39.482102,"median":-23.614139,"eighty":-11.765186,"marketCap":879314818},{"date":"2022-07-15","current":-14.121409,"twenty":-39.398794,"median":-22.27928,"eighty":-11.796764,"marketCap":806360676},{"date":"2022-07-22","current":-12.903025,"twenty":-39.172792,"median":-21.750757,"eighty":-11.911231,"marketCap":736788515},{"date":"2022-07-29","current":-12.573046,"twenty":-38.953658,"median":-21.547478,"eighty":-12.213523,"marketCap":717946054},{"date":"2022-08-05","current":-13.613749,"twenty":-38.669722,"median":-21.018955,"eighty":-12.041695,"marketCap":777372276},{"date":"2022-08-12","current":-12.344485,"twenty":-38.522289,"median":-20.829229,"eighty":-12.041695,"marketCap":811402986},{"date":"2022-08-19","current":-11.814173,"twenty":-38.3924,"median":-20.361689,"eighty":-12.011358,"marketCap":776545578},{"date":"2022-08-26","current":-11.593209,"twenty":-38.23687,"median":-20.124532,"eighty":-11.962731,"marketCap":762021658},{"date":"2022-09-02","current":-12.337119,"twenty":-37.455071,"median":-19.873822,"eighty":-11.913447,"marketCap":810918855},{"date":"2022-09-09","current":-12.955817,"twenty":-37.250109,"median":-19.121693,"eighty":-11.888628,"marketCap":851585830},{"date":"2022-09-16","current":-13.022106,"twenty":-37.041696,"median":-18.281477,"eighty":-11.956614,"marketCap":855943006},{"date":"2022-09-23","current":-12.35185,"twenty":-36.880877,"median":-17.841041,"eighty":-11.986524,"marketCap":811887116},{"date":"2022-09-30","current":-14.318424,"twenty":-36.797586,"median":-17.305742,"eighty":-12.008096,"marketCap":941150003},{"date":"2022-10-07","current":-13.684996,"twenty":-36.724185,"median":-17.197327,"eighty":-12.034926,"marketCap":899514766},{"date":"2022-10-14","current":-15.268566,"twenty":-36.558528,"median":-17.07536,"eighty":-12.071402,"marketCap":1003602858},{"date":"2022-10-21","current":-14.649869,"twenty":-36.430833,"median":-16.885634,"eighty":-12.126467,"marketCap":962935882},{"date":"2022-10-28","current":-26.02948,"twenty":-36.184709,"median":-16.736563,"eighty":-12.171497,"marketCap":1710917752},{"date":"2022-11-04","current":-26.315342,"twenty":-36.021716,"median":-16.933065,"eighty":-12.236034,"marketCap":1729707455},{"date":"2022-11-11","current":-24.734689,"twenty":-35.340256,"median":-17.102464,"eighty":-12.277734,"marketCap":1806127008},{"date":"2022-11-18","current":-23.845786,"twenty":-34.8916,"median":-17.231207,"eighty":-12.315206,"marketCap":1741219318},{"date":"2022-11-25","current":-24.927929,"twenty":-34.74665,"median":-17.380277,"eighty":-12.340065,"marketCap":1820237375},{"date":"2022-12-02","current":-27.849714,"twenty":-34.474005,"median":-18.091751,"eighty":-12.347431,"marketCap":2033586128},{"date":"2022-12-09","current":-23.96946,"twenty":-34.322098,"median":-18.484755,"eighty":-12.360689,"marketCap":1750249953},{"date":"2022-12-16","current":-22.856399,"twenty":-34.14259,"median":-19.528249,"eighty":-12.383179,"marketCap":1668974238},{"date":"2022-12-23","current":-21.982955,"twenty":-33.863115,"median":-19.989013,"eighty":-12.401198,"marketCap":1605195378},{"date":"2022-12-30","current":-23.01872,"twenty":-33.499619,"median":-20.151635,"eighty":-12.411064,"marketCap":1680826946},{"date":"2023-01-06","current":-21.526909,"twenty":-33.039467,"median":-20.361689,"eighty":-12.425505,"marketCap":1571894911},{"date":"2023-01-13","current":-25.067062,"twenty":-32.880245,"median":-20.692113,"eighty":-12.43287,"marketCap":1830396839},{"date":"2023-01-20","current":-23.868975,"twenty":-32.667097,"median":-20.829229,"eighty":-12.43287,"marketCap":1742912562},{"date":"2023-01-27","current":-25.09025,"twenty":-32.607408,"median":-21.018955,"eighty":-12.454243,"marketCap":1832090083},{"date":"2023-02-03","current":-23.242878,"twenty":-32.23948,"median":-21.295022,"eighty":-12.497137,"marketCap":1697194972},{"date":"2023-02-10","current":-22.160736,"twenty":-32.032331,"median":-21.41483,"eighty":-12.512417,"marketCap":1618176916},{"date":"2023-02-17","current":-25.144358,"twenty":-31.813161,"median":-21.547478,"eighty":-12.561215,"marketCap":1836040986},{"date":"2023-02-24","current":-23.258337,"twenty":-31.529064,"median":-21.655893,"eighty":-12.61268,"marketCap":1698323802},{"date":"2023-03-03","current":-23.150123,"twenty":-31.258268,"median":-21.825291,"eighty":-12.655311,"marketCap":1690421996},{"date":"2023-03-10","current":-20.483415,"twenty":-31.11996,"median":-21.77786,"eighty":-12.694101,"marketCap":1495698928},{"date":"2023-03-17","current":-21.066674,"twenty":-31.002698,"median":-21.750757,"eighty":-12.767298,"marketCap":1724391538},{"date":"2023-03-24","current":-19.133888,"twenty":-30.058054,"median":-21.655893,"eighty":-12.828665,"marketCap":1566185277},{"date":"2023-03-31","current":-18.073973,"twenty":-29.453641,"median":-21.544923,"eighty":-12.858593,"marketCap":1479427005},{"date":"2023-04-06","current":-16.335159,"twenty":-29.377022,"median":-21.488261,"eighty":-12.867431,"marketCap":1337098075},{"date":"2023-04-14","current":-19.85701,"twenty":-29.270224,"median":-21.3442,"eighty":-12.881669,"marketCap":1625375676},{"date":"2023-04-21","current":-23.2682,"twenty":-29.265532,"median":-21.362124,"eighty":-12.924142,"marketCap":1904595240},{"date":"2023-04-28","current":-23.815932,"twenty":-29.188024,"median":-21.526909,"eighty":-12.97644,"marketCap":1949429276},{"date":"2023-05-04","current":-25.759189,"twenty":-29.047085,"median":-21.547478,"eighty":-13.010321,"marketCap":2108492618},{"date":"2023-05-12","current":-25.430668,"twenty":-28.87091,"median":-21.684156,"eighty":-13.022106,"marketCap":2275968472},{"date":"2023-05-19","current":-24.709927,"twenty":-28.710998,"median":-21.777538,"eighty":-13.036805,"marketCap":2211464368},{"date":"2023-05-26","current":-24.551205,"twenty":-28.635108,"median":-21.836093,"eighty":-13.095599,"marketCap":2197259175},{"date":"2023-06-02","current":-26.982834,"twenty":-28.385754,"median":-21.975225,"eighty":-13.131082,"marketCap":2414882725},{"date":"2023-06-09","current":-26.976485,"twenty":-28.315219,"median":-21.998414,"eighty":-13.150094,"marketCap":2414314517},{"date":"2023-06-16","current":-28.366895,"twenty":-28.315219,"median":-22.102764,"eighty":-13.18266,"marketCap":2538752003},{"date":"2023-06-23","current":-26.709832,"twenty":-28.306861,"median":-22.335952,"eighty":-13.208307,"marketCap":2390449793},{"date":"2023-06-30","current":-27.198697,"twenty":-28.268754,"median":-22.446731,"eighty":-13.258915,"marketCap":2434201786},{"date":"2023-07-07","current":-25.414655,"twenty":-28.133689,"median":-22.531756,"eighty":-13.410685,"marketCap":2274535423},{"date":"2023-07-14","current":-26.627296,"twenty":-28.013291,"median":-22.709537,"eighty":-13.436068,"marketCap":2383063093},{"date":"2023-07-21","current":-28.538315,"twenty":-28.133689,"median":-22.767353,"eighty":-13.469912,"marketCap":2554093611},{"date":"2023-07-28","current":-29.477953,"twenty":-28.312487,"median":-22.83321,"eighty":-13.57127,"marketCap":2638188351},{"date":"2023-08-04","current":-28.862109,"twenty":-28.557674,"median":-22.893801,"eighty":-13.610321,"marketCap":2583072204},{"date":"2023-08-11","current":-24.764415,"twenty":-28.557674,"median":-23.065098,"eighty":-13.658962,"marketCap":2479438043},{"date":"2023-08-18","current":-23.414561,"twenty":-28.426575,"median":-23.157853,"eighty":-13.68205,"marketCap":2344289281},{"date":"2023-08-25","current":-23.824644,"twenty":-28.373244,"median":-23.263269,"eighty":-13.705606,"marketCap":2385347133},{"date":"2023-09-01","current":-25.954793,"twenty":-28.336421,"median":-23.39747,"eighty":-13.749072,"marketCap":2598619862},{"date":"2023-09-08","current":-26.99139,"twenty":-28.32557,"median":-23.414561,"eighty":-13.761194,"marketCap":2702404987},{"date":"2023-09-15","current":-27.338821,"twenty":-28.315219,"median":-23.555926,"eighty":-13.769146,"marketCap":2737190112},{"date":"2023-09-22","current":-24.587852,"twenty":-28.305414,"median":-23.621628,"eighty":-13.830806,"marketCap":2461760356},{"date":"2023-09-29","current":-26.518657,"twenty":-28.280196,"median":-23.696285,"eighty":-13.88343,"marketCap":2655074408},{"date":"2023-10-06","current":-35.546163,"twenty":-28.305414,"median":-23.77622,"eighty":-13.903115,"marketCap":3558917393},{"date":"2023-10-13","current":-34.236178,"twenty":-28.379593,"median":-23.8154,"eighty":-13.955573,"marketCap":3427760367},{"date":"2023-10-20","current":-29.064584,"twenty":-28.744733,"median":-23.845786,"eighty":-14.026646,"marketCap":2909975237},{"date":"2023-10-27","current":-33.614382,"twenty":-28.862109,"median":-23.861246,"eighty":-14.053721,"marketCap":3365505501},{"date":"2023-11-03","current":-34.337138,"twenty":-29.211299,"median":-23.903358,"eighty":-14.060633,"marketCap":3437868548},{"date":"2023-11-10","current":-35.464886,"twenty":-29.44822,"median":-23.947665,"eighty":-14.060633,"marketCap":3550779854},{"date":"2023-11-17","current":-31.866939,"twenty":-29.833491,"median":-23.964282,"eighty":-14.121409,"marketCap":3634424412},{"date":"2023-11-24","current":-34.755447,"twenty":-30.824236,"median":-23.993876,"eighty":-14.178851,"marketCap":3963858712},{"date":"2023-12-01","current":-35.89767,"twenty":-31.144585,"median":-24.054485,"eighty":-14.230533,"marketCap":4094129310},{"date":"2023-12-08","current":-38.896007,"twenty":-31.669705,"median":-24.123342,"eighty":-14.266938,"marketCap":4436089628},{"date":"2023-12-15","current":-43.38253,"twenty":-31.894239,"median":-24.22903,"eighty":-14.297696,"marketCap":4947777505},{"date":"2023-12-22","current":-38.720281,"twenty":-32.410785,"median":-24.257295,"eighty":-14.315478,"marketCap":4416047998},{"date":"2023-12-29","current":-41.224386,"twenty":-32.610609,"median":-24.317291,"eighty":-14.330209,"marketCap":4701641231},{"date":"2024-01-05","current":-39.862504,"twenty":-32.805979,"median":-24.337125,"eighty":-14.347886,"marketCap":4546318596},{"date":"2024-01-12","current":-40.768595,"twenty":-33.028713,"median":-24.382811,"eighty":-14.347886,"marketCap":4649658252},{"date":"2024-01-19","current":-40.362227,"twenty":-33.4798,"median":-24.425506,"eighty":-14.383306,"marketCap":4603311982},{"date":"2024-01-26","current":-41.899836,"twenty":-34.069015,"median":-24.465511,"eighty":-14.439543,"marketCap":4778676248},{"date":"2024-02-02","current":-42.657657,"twenty":-34.347946,"median":-24.545441,"eighty":-14.462864,"marketCap":4865105779},{"date":"2024-02-09","current":-44.25018,"twenty":-34.775757,"median":-24.580747,"eighty":-14.478998,"marketCap":5046733055},{"date":"2024-02-16","current":-46.402832,"twenty":-34.95921,"median":-24.709927,"eighty":-14.504403,"marketCap":5292243027},{"date":"2024-02-23","current":-45.705417,"twenty":-35.262302,"median":-24.734689,"eighty":-14.556028,"marketCap":5212702806},{"date":"2024-03-01","current":-42.698561,"twenty":-35.546163,"median":-24.77209,"eighty":-14.598111,"marketCap":5389369708},{"date":"2024-03-08","current":-42.363551,"twenty":-36.021716,"median":-24.804256,"eighty":-14.610096,"marketCap":5347085067},{"date":"2024-03-15","current":-42.942205,"twenty":-36.558528,"median":-24.831986,"eighty":-14.622658,"marketCap":5420122174},{"date":"2024-03-22","current":-40.373794,"twenty":-36.868914,"median":-24.992974,"eighty":-14.641549,"marketCap":5095939926},{"date":"2024-03-28","current":-38.90178,"twenty":-37.200741,"median":-25.005225,"eighty":-14.658707,"marketCap":4910143776},{"date":"2024-04-05","current":-36.495798,"twenty":-37.374818,"median":-25.061735,"eighty":-14.675345,"marketCap":4606463172},{"date":"2024-04-12","current":-34.516193,"twenty":-37.267525,"median":-25.09025,"eighty":-14.735959,"marketCap":4356599384},{"date":"2024-04-19","current":-32.008693,"twenty":-37.255768,"median":-25.199563,"eighty":-14.847142,"marketCap":4040105252},{"date":"2024-04-26","current":-33.536542,"twenty":-37.200741,"median":-25.298949,"eighty":-14.916986,"marketCap":4232948842},{"date":"2024-05-03","current":-37.038357,"twenty":-37.101882,"median":-25.381429,"eighty":-14.992892,"marketCap":4674944398},{"date":"2024-05-10","current":-29.955741,"twenty":-36.987234,"median":-25.430668,"eighty":-15.077502,"marketCap":4358829897},{"date":"2024-05-17","current":-32.227266,"twenty":-36.898587,"median":-25.520776,"eighty":-15.184387,"marketCap":4689357283},{"date":"2024-05-24","current":-29.583069,"twenty":-36.872823,"median":-25.569485,"eighty":-15.320748,"marketCap":4304602748},{"date":"2024-05-31","current":-29.494337,"twenty":-36.839925,"median":-25.653696,"eighty":-15.399184,"marketCap":4291691522},{"date":"2024-06-07","current":-36.206872,"twenty":-36.753783,"median":-25.749363,"eighty":-15.460497,"marketCap":5268425769},{"date":"2024-06-14","current":-35.040054,"twenty":-36.747932,"median":-25.822877,"eighty":-15.703127,"marketCap":5098643147},{"date":"2024-06-21","current":-34.782732,"twenty":-36.712369,"median":-25.874326,"eighty":-15.710732,"marketCap":5061200592},{"date":"2024-06-28","current":-34.148302,"twenty":-36.661942,"median":-25.890823,"eighty":-15.727693,"marketCap":4968885326},{"date":"2024-07-05","current":-31.965508,"twenty":-36.495798,"median":-25.923936,"eighty":-15.787932,"marketCap":4651269166},{"date":"2024-07-12","current":-34.600833,"twenty":-36.461894,"median":-25.988967,"eighty":-15.815036,"marketCap":5034732578},{"date":"2024-07-15","current":-34.893647,"twenty":-36.45154,"median":-26.009223,"eighty":-15.833901,"marketCap":5077339624},{"date":"2024-08-02","current":-33.815559,"twenty":-36.441187,"median":-26.02948,"eighty":-15.852766,"marketCap":4920468228},{"date":"2024-08-09","current":-26.219913,"twenty":-36.38746,"median":-26.039924,"eighty":-15.936679,"marketCap":4551383634},{"date":"2024-08-16","current":-26.843308,"twenty":-36.294826,"median":-26.091487,"eighty":-16.068186,"marketCap":4659595631},{"date":"2024-08-23","current":-30.983098,"twenty":-36.163411,"median":-26.131203,"eighty":-16.227286,"marketCap":5378201049},{"date":"2024-08-30","current":-31.916324,"twenty":-36.072704,"median":-26.182617,"eighty":-16.27309,"marketCap":5540195056},{"date":"2024-09-06","current":-31.714747,"twenty":-36.030193,"median":-26.219913,"eighty":-16.289352,"marketCap":5505204350},{"date":"2024-09-13","current":-30.490355,"twenty":-36.010736,"median":-26.305926,"eighty":-16.294773,"marketCap":5292668213},{"date":"2024-09-20","current":-41.470105,"twenty":-36.185141,"median":-26.404281,"eighty":-16.320196,"marketCap":7198588141},{"date":"2024-09-27","current":-41.023082,"twenty":-36.489017,"median":-26.487136,"eighty":-16.335438,"marketCap":7120991681},{"date":"2024-10-04","current":-42.063985,"twenty":-36.839925,"median":-26.521016,"eighty":-16.36506,"marketCap":7301676910},{"date":"2024-10-11","current":-41.629121,"twenty":-37.123057,"median":-26.535236,"eighty":-16.487703,"marketCap":7226190975},{"date":"2024-10-18","current":-41.519389,"twenty":-37.41054,"median":-26.571994,"eighty":-16.548812,"marketCap":7207143122},{"date":"2024-10-25","current":-38.052666,"twenty":-38.109047,"median":-26.647191,"eighty":-16.659123,"marketCap":6605372068},{"date":"2024-10-31","current":-36.674918,"twenty":-38.085179,"median":-26.68862,"eighty":-16.674608,"marketCap":6366215694},{"date":"2024-11-08","current":-38.239617,"twenty":-38.115014,"median":-26.712656,"eighty":-16.695908,"marketCap":6637823966},{"date":"2024-11-15","current":-28.56865,"twenty":-38.204749,"median":-26.80059,"eighty":-16.723012,"marketCap":6407519770},{"date":"2024-11-22","current":-29.37648,"twenty":-38.115014,"median":-26.887601,"eighty":-16.736563,"marketCap":6588703796},{"date":"2024-11-29","current":-30.627824,"twenty":-38.091146,"median":-26.954676,"eighty":-16.844978,"marketCap":6869361404},{"date":"2024-12-06","current":-29.693276,"twenty":-38.059169,"median":-26.97966,"eighty":-16.893765,"marketCap":6659756355},{"date":"2024-12-13","current":-27.504216,"twenty":-37.747042,"median":-27.063091,"eighty":-16.953393,"marketCap":6168783172},{"date":"2024-12-20","current":-26.813601,"twenty":-37.583519,"median":-27.063095,"eighty":-17.053677,"marketCap":6013888593},{"date":"2024-12-27","current":-25.996268,"twenty":-37.492453,"median":-26.987112,"eighty":-17.091622,"marketCap":5830572991},{"date":"2025-01-03","current":-25.340501,"twenty":-37.40921,"median":-26.975395,"eighty":-17.134988,"marketCap":5683494194},{"date":"2025-01-10","current":-24.789276,"twenty":-37.336436,"median":-26.943787,"eighty":-17.189196,"marketCap":5559862741},{"date":"2025-01-17","current":-24.073317,"twenty":-37.267588,"median":-26.849001,"eighty":-17.21901,"marketCap":5399283958},{"date":"2025-01-24","current":-26.515813,"twenty":-37.267337,"median":-26.813601,"eighty":-17.251535,"marketCap":5947099188},{"date":"2025-01-31","current":-27.798837,"twenty":-37.238414,"median":-26.828454,"eighty":-17.305742,"marketCap":6234862052},{"date":"2025-02-07","current":-27.466201,"twenty":-37.144232,"median":-26.880129,"eighty":-17.454813,"marketCap":6160256865},{"date":"2025-02-14","current":-25.644625,"twenty":-37.038357,"median":-26.846155,"eighty":-17.471277,"marketCap":5751704651},{"date":"2025-02-21","current":-26.100811,"twenty":-36.968696,"median":-26.785736,"eighty":-17.56652,"marketCap":5854020336},{"date":"2025-02-28","current":-20.411984,"twenty":-36.918696,"median":-26.712656,"eighty":-17.605929,"marketCap":5322547194},{"date":"2025-03-07","current":-20.027736,"twenty":-36.886624,"median":-26.694963,"eighty":-17.787173,"marketCap":5222352284},{"date":"2025-03-14","current":-20.450586,"twenty":-36.865624,"median":-26.667087,"eighty":-17.99777,"marketCap":5332613081},{"date":"2025-03-21","current":-21.318253,"twenty":-36.86125,"median":-26.590122,"eighty":-18.067045,"marketCap":5558862508},{"date":"2025-03-28","current":-20.214449,"twenty":-36.776416,"median":-26.54476,"eighty":-18.073973,"marketCap":5271038870},{"date":"2025-04-04","current":-18.759184,"twenty":-36.749395,"median":-26.523364,"eighty":-18.088195,"marketCap":4891569894},{"date":"2025-04-11","current":-17.021104,"twenty":-36.712369,"median":-26.515813,"eighty":-17.99777,"marketCap":4438355060},{"date":"2025-04-17","current":-19.212238,"twenty":-36.686342,"median":-26.48036,"eighty":-18.046198,"marketCap":5009706462},{"date":"2025-04-25","current":-20.313297,"twenty":-36.567446,"median":-26.420448,"eighty":-18.064693,"marketCap":5296814121},{"date":"2025-05-02","current":-20.931098,"twenty":-36.475456,"median":-26.315342,"eighty":-18.073973,"marketCap":5457909441},{"date":"2025-05-09","current":-17.089596,"twenty":-36.430833,"median":-26.28219,"eighty":-18.073973,"marketCap":5141507574},{"date":"2025-05-16","current":-16.946387,"twenty":-36.395868,"median":-26.219913,"eighty":-17.80499,"marketCap":5098422315},{"date":"2025-05-23","current":-17.478647,"twenty":-36.366622,"median":-26.183178,"eighty":-17.602029,"marketCap":5258555860},{"date":"2025-05-30","current":-17.84383,"twenty":-36.316227,"median":-26.173393,"eighty":-17.576984,"marketCap":5368423271},{"date":"2025-06-06","current":-18.638639,"twenty":-36.238974,"median":-26.132081,"eighty":-17.5849,"marketCap":5607546458},{"date":"2025-06-13","current":-18.595677,"twenty":-36.163411,"median":-26.113701,"eighty":-17.59813,"marketCap":5594620881},{"date":"2025-06-20","current":-18.027615,"twenty":-36.085461,"median":-26.070805,"eighty":-17.639806,"marketCap":5423716020},{"date":"2025-06-27","current":-18.886868,"twenty":-36.030193,"median":-26.0467,"eighty":-17.760818,"marketCap":5682227574},{"date":"2025-07-03","current":-19.209088,"twenty":-36.013239,"median":-26.033148,"eighty":-17.765211,"marketCap":5779169407},{"date":"2025-07-11","current":-19.588592,"twenty":-36.000722,"median":-25.992618,"eighty":-17.808028,"marketCap":5893345343},{"date":"2025-07-18","current":-20.452619,"twenty":-35.944936,"median":-25.938285,"eighty":-17.831509,"marketCap":6153293072},{"date":"2025-07-25","current":-19.590979,"twenty":-35.89767,"median":-25.890823,"eighty":-17.84383,"marketCap":5894063431},{"date":"2025-08-01","current":-18.700696,"twenty":-35.632894,"median":-25.842988,"eighty":-17.901113,"marketCap":5626216737},{"date":"2025-08-08","current":-15.091965,"twenty":-35.546163,"median":-25.760514,"eighty":-17.901113,"marketCap":5181720482},{"date":"2025-08-15","current":-16.128628,"twenty":-35.546163,"median":-25.736495,"eighty":-17.765211,"marketCap":5537651481},{"date":"2025-08-22","current":-15.467102,"twenty":-35.531375,"median":-25.649161,"eighty":-17.58128,"marketCap":5310521245},{"date":"2025-08-29","current":-15.964821,"twenty":-35.519203,"median":-25.58458,"eighty":-17.497742,"marketCap":5481409708},{"date":"2025-09-05","current":-16.731351,"twenty":-35.510641,"median":-25.545281,"eighty":-17.424999,"marketCap":5744592363},{"date":"2025-09-12","current":-17.266872,"twenty":-35.50464,"median":-25.47316,"eighty":-17.241786,"marketCap":5928459698},{"date":"2025-09-19","current":-17.002262,"twenty":-35.503675,"median":-25.430668,"eighty":-17.086749,"marketCap":5837607603},{"date":"2025-09-26","current":-16.279834,"twenty":-35.472644,"median":-25.414774,"eighty":-17.026191,"marketCap":5589566964},{"date":"2025-10-03","current":-17.611286,"twenty":-35.429994,"median":-25.348204,"eighty":-17.0428,"marketCap":6046711630},{"date":"2025-10-10","current":-18.480719,"twenty":-35.390572,"median":-25.316462,"eighty":-17.048543,"marketCap":6345225656},{"date":"2025-10-17","current":-18.988939,"twenty":-35.231658,"median":-25.206194,"eighty":-17.070092,"marketCap":6519719361},{"date":"2025-10-24","current":-19.087643,"twenty":-35.163828,"median":-25.163231,"eighty":-17.086749,"marketCap":6553608634},{"date":"2025-10-31","current":-18.557636,"twenty":-35.134293,"median":-25.089064,"eighty":-17.091971,"marketCap":7078531848},{"date":"2025-11-07","current":-18.27413,"twenty":-35.113548,"median":-25.061735,"eighty":-17.100484,"marketCap":6970392767},{"date":"2025-11-14","current":-18.0473,"twenty":-35.078925,"median":-25.005225,"eighty":-17.167513,"marketCap":6883871776},{"date":"2025-11-21","current":-20.58818,"twenty":-35.046287,"median":-24.960451,"eighty":-17.205458,"marketCap":7853052287},{"date":"2025-11-28","current":-20.832165,"twenty":-35.019071,"median":-24.831986,"eighty":-17.234059,"marketCap":7946116882},{"date":"2025-12-05","current":-21.755868,"twenty":-34.970678,"median":-24.804256,"eighty":-17.250726,"marketCap":8298449567},{"date":"2025-12-12","current":-21.562456,"twenty":-34.915285,"median":-24.794028,"eighty":-17.260737,"marketCap":8224675217},{"date":"2025-12-19","current":-20.64629,"twenty":-34.892419,"median":-24.779765,"eighty":-17.290194,"marketCap":7875217767},{"date":"2025-12-26","current":-21.531917,"twenty":-34.8916,"median":-24.750148,"eighty":-17.320435,"marketCap":8213026635},{"date":"2026-01-02","current":-20.479345,"twenty":-34.884679,"median":-24.734689,"eighty":-17.343911,"marketCap":7811538854},{"date":"2026-01-09","current":-20.902817,"twenty":-34.842144,"median":-24.714754,"eighty":-17.370686,"marketCap":7973065853},{"date":"2026-01-16","current":-21.613354,"twenty":-34.777275,"median":-24.687901,"eighty":-17.458106,"marketCap":8244089519},{"date":"2026-01-23","current":-22.800296,"twenty":-34.755447,"median":-24.587852,"eighty":-17.471277,"marketCap":8696831059},{"date":"2026-01-30","current":-20.853954,"twenty":-34.755447,"median":-24.548323,"eighty":-17.478647,"marketCap":7954428122},{"date":"2026-02-06","current":-20.542458,"twenty":-34.739533,"median":-24.51381,"eighty":-17.497742,"marketCap":7835612589},{"date":"2026-02-13","current":-20.630003,"twenty":-34.71867,"median":-24.448096,"eighty":-17.500128,"marketCap":7869005190},{"date":"2026-02-20","current":-21.18581,"twenty":-34.663442,"median":-24.415729,"eighty":-17.508411,"marketCap":8081009376},{"date":"2026-02-27","current":-18.973555,"twenty":-34.610593,"median":-24.382811,"eighty":-17.53466,"marketCap":8070913939},{"date":"2026-03-06","current":-18.50575,"twenty":-34.543546,"median":-24.337125,"eighty":-17.551029,"marketCap":7871920310},{"date":"2026-03-13","current":-18.112089,"twenty":-34.518799,"median":-24.274595,"eighty":-17.570018,"marketCap":7704466098},{"date":"2026-03-20","current":-17.938361,"twenty":-34.510585,"median":-24.237361,"eighty":-17.579848,"marketCap":7630566117},{"date":"2026-03-27","current":-18.123178,"twenty":-34.507969,"median":-24.160683,"eighty":-17.579848,"marketCap":7709183118}],"updateTime":1774752621833},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NUVL\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2600559708","title":"What's Going On With Royalty Pharma Stock Wednesday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2600559708","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600559708?lang=en_us&edition=fundamental","pubTime":"2025-12-31 23:47","pubTimestamp":1767196020,"startTime":"0","endTime":"0","summary":"Royalty Pharma plc  stock has gained around 53% year to date, as per data from Benzinga Pro.On Monday, Royalty Pharma acquired the final portion of PTC Therapeutics Inc.’s  remaining royalty on Roche Holdings AG’s  Evrysdi for $240 million upfront and up to $60 million in sales-based milestones.Evrysdi, marketed by Roche, is an orally administered survival motor neuron-2  splicing modifier for the treatment of spinal muscular atrophy .Also Read: Denali Flags Minimal Delay After FDA Halts Rare Disease Trial Start. The FDA approved Evrysdi in 2020 and has treated over 21,000 patients worldwide.In 2024, Evrysdi generated sales of approximately 1.6 billion Swiss francs , representing 18% year-over-year growth at constant exchange rates, and is projected to reach 2.3 billion Swiss francs  of sales by 2030 based on analyst consensus.In March 2025, Novartis AG  shared safety and efficacy results from the Phase 3 program for investigational intrathecal onasemnogene abeparvovec  in a broad popu","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/31/Genetic-Research-And-Biotech-Science-Con.jpeg?optimize=medium&dpr=2&auto=webp&width=630","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/31/Genetic-Research-And-Biotech-Science-Con.jpeg?optimize=medium&dpr=2&auto=webp&width=630"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/health-care/25/12/49649858/whats-going-on-with-royalty-pharma-stock-wednesday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/12/49649858/whats-going-on-with-royalty-pharma-stock-wednesday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["IE0009355771.USD","IE00B19Z9Z06.USD","SMA","IE00B894F039.SGD","LU0109394709.USD","RPRX","IE00BJJMRZ35.SGD","BK4533","LU0211331839.USD","LU0889565916.HKD","IE00B4R5TH58.HKD","IE0002141913.USD","LU0320765992.SGD","BK4578","BK4588","BK4139","BIIB","IE00BJT1NW94.SGD","LU0208291251.USD","NVS","BK4585","NUVL","IE00B2B36J28.USD","BK4539","PTCT","LU0070302665.USD","LU0320765489.SGD","LU0234570918.USD","IE00B19Z9P08.USD","BK4532","BK4217","IE00BFTCPJ56.SGD","BK4007"],"gpt_icon":0},{"id":"2593487135","title":"BRIEF-Nuvalent Files For Mixed Shelf Offering Size Not Disclosed - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2593487135","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593487135?lang=en_us&edition=fundamental","pubTime":"2025-12-22 20:54","pubTimestamp":1766408070,"startTime":"0","endTime":"0","summary":"BRIEF-Nuvalent Files For Mixed Shelf Offering Size Not Disclosed - SEC FilingDec 22  - Nuvalent Inc NUVL.O:NUVALENT INC: FILES FOR MIXED SHELF OFFERING; SIZE NOT DISCLOSED - SEC FILINGSource text: [ID:n0001193125-25-327592]Further company coverage: NUVL.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nFWN3XS0E1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVL","BK4539","BK4139"],"gpt_icon":0},{"id":"2593487186","title":"Nuvalent Inc: Files for Mixed Shelf Offering; Size Not Disclosed - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2593487186","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593487186?lang=en_us&edition=fundamental","pubTime":"2025-12-22 20:53","pubTimestamp":1766407994,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nFWN3XS0E1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","NUVL","BK4139"],"gpt_icon":0},{"id":"2593348101","title":"Nuvalent Inc. to Present at J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2593348101","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593348101?lang=en_us&edition=fundamental","pubTime":"2025-12-22 19:30","pubTimestamp":1766403019,"startTime":"0","endTime":"0","summary":"Nuvalent Inc., a clinical-stage biopharmaceutical company focused on targeted cancer therapies, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 9:00 a.m. PT in San Francisco. A live webcast of the presentation will be available in the Investors section of the company's website and will be archived for 30 days following the event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvalent Inc. published the original content used to generate this news brief via PR Newswire  on December 22, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDLbZqZRB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","NUVL"],"gpt_icon":0},{"id":"2592972196","title":"Nuvalent Is Maintained at Overweight by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2592972196","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592972196?lang=en_us&edition=fundamental","pubTime":"2025-12-20 00:32","pubTimestamp":1766161920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NUVL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 19, 2025 11:32 ET (16:32 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVL"],"gpt_icon":0},{"id":"2592130053","title":"Nuvalent Inc : JP Morgan Cuts Target Price to $145 From $147","url":"https://stock-news.laohu8.com/highlight/detail?id=2592130053","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592130053?lang=en_us&edition=fundamental","pubTime":"2025-12-19 13:34","pubTimestamp":1766122483,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nFWN3XP012:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","NUVL"],"gpt_icon":0},{"id":"2592798953","title":"How Investors Are Reacting To Royalty Pharma (RPRX) Expanding Oncology Royalties With Nuvalent Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2592798953","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592798953?lang=en_us&edition=fundamental","pubTime":"2025-12-17 05:24","pubTimestamp":1765920253,"startTime":"0","endTime":"0","summary":"Royalty Pharma recently acquired a pre-existing royalty interest in Nuvalent’s cancer drug candidates neladalkib and zidesamtinib for up to US$315,000,000, securing potential royalty streams through about 2041–2042.\nThis move broadens Royalty Pharma’s exposure to next-generation lung cancer treatments targeting ALK and ROS1 mutations, underscoring its focus on late-stage oncology innovation.\nWe’ll now examine how this oncology-focused royalty acquisition could influence Royalty Pharma’s...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rprx/royalty-pharma/news/how-investors-are-reacting-to-royalty-pharma-rprx-expanding","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rprx/royalty-pharma/news/how-investors-are-reacting-to-royalty-pharma-rprx-expanding","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","BK4539","BK4211","BK4139","ISBC","RPRX","NUVL"],"gpt_icon":0},{"id":"2591981376","title":"Royalty Pharma  - Buys Low-Single Digit Royalty on Neladalkib and Zidesamtinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2591981376","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591981376?lang=en_us&edition=fundamental","pubTime":"2025-12-16 20:15","pubTimestamp":1765887300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nTUA9P0VT1:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NUVL","BK4139","RPRX","BK4007","BK4539"],"gpt_icon":0},{"id":"2591327981","title":"Royalty Pharma  - Royalty Duration for Both Therapies Extends Through 2041 to 2042","url":"https://stock-news.laohu8.com/highlight/detail?id=2591327981","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591327981?lang=en_us&edition=fundamental","pubTime":"2025-12-16 20:15","pubTimestamp":1765887300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nTUA9P0VT1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RPRX","BK4139","BK4539","NUVL","BK4007"],"gpt_icon":0},{"id":"2591578981","title":"Royalty Pharma Acquires Royalty Interest in Nuvalent’s Neladalkib and Zidesamtinib for Up to $315 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2591578981","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591578981?lang=en_us&edition=fundamental","pubTime":"2025-12-16 20:15","pubTimestamp":1765887300,"startTime":"0","endTime":"0","summary":"NEW YORK, Dec.  16, 2025  (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired a pre-existing royalty interest in Nuvalent’s neladalkib and zidesamtinib from an u","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/16/3206110/0/en/Royalty-Pharma-Acquires-Royalty-Interest-in-Nuvalent-s-Neladalkib-and-Zidesamtinib-for-Up-to-315-Million.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","NUVL"],"gpt_icon":0},{"id":"2590541939","title":"Nuvalent Inc. Files Initial Statement of Beneficial Ownership for Director Ron Squarer","url":"https://stock-news.laohu8.com/highlight/detail?id=2590541939","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590541939?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:31","pubTimestamp":1765488682,"startTime":"0","endTime":"0","summary":"Nuvalent Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing lists Ron Squarer as the beneficial owner in the capacity of Director. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvalent Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 11, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL3jk3Vk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Nuvalent Inc. Files Initial Statement of Beneficial Ownership for Director Ron Squarer","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","NUVL"],"gpt_icon":0},{"id":"2590539585","title":"Nuvalent CFO Alexandra Balcom Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2590539585","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590539585?lang=en_us&edition=fundamental","pubTime":"2025-12-11 05:31","pubTimestamp":1765402293,"startTime":"0","endTime":"0","summary":"Alexandra Balcom, Chief Financial Officer of Nuvalent Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvalent Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 10, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nNDL3lQDGl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Nuvalent CFO Alexandra Balcom Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVL","BK4539","BK4139"],"gpt_icon":0},{"id":"2590558653","title":"Press Release: Nuvalent Appoints Ron Squarer to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2590558653","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590558653?lang=en_us&edition=fundamental","pubTime":"2025-12-11 05:01","pubTimestamp":1765400460,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Dec. 10, 2025 /PRNewswire/ -- Nuvalent, Inc. , a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced the appointment of Ron Squarer to its Board of Directors.\"We welcome Ron to our Board of Directors, where his personal dedication to advancing oncology therapeutics, demonstrated success in evolving research and development organizations to fully integrated businesses, and proven global commercial acumen will strengthen and sharpen our pre-launch preparation,\" said James Porter, Ph.D., Chief Executive Officer at Nuvalent. \"We look forward to leveraging his deep expertise as we advance toward the potential first approval and launch of zidesamtinib for TKI pre-treated ROS1-positive non-small cell lung cancer in 2026.\". Nuvalent, Inc.  is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","NUVL","BK4139"],"gpt_icon":0},{"id":"2590535817","title":"Nuvalent (NUVL) Valuation After FDA Breakthrough Designation and Investor Optimism in Lung Cancer Franchise","url":"https://stock-news.laohu8.com/highlight/detail?id=2590535817","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590535817?lang=en_us&edition=fundamental","pubTime":"2025-12-10 21:29","pubTimestamp":1765373396,"startTime":"0","endTime":"0","summary":"Nuvalent (NUVL) has been on investors radar after the FDA accepted its New Drug Application for Zide with Breakthrough Therapy Designation, a key step that could accelerate its lung cancer franchise.\nSee our latest analysis for Nuvalent.\nDespite a small pullback in the latest session, Nuvalent’s roughly 13 percent 1 month share price return and robust 3 year total shareholder return of about 225 percent suggest momentum is still building around its growing lung cancer pipeline and recent...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nuvl/nuvalent/news/nuvalent-nuvl-valuation-after-fda-breakthrough-designation-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nuvl/nuvalent/news/nuvalent-nuvl-valuation-after-fda-breakthrough-designation-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4539","NUVL","BK4139","DCF"],"gpt_icon":0},{"id":"2588069519","title":"Nuvalent Chief Development Officer Darlene Noci Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2588069519","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588069519?lang=en_us&edition=fundamental","pubTime":"2025-12-03 05:31","pubTimestamp":1764711091,"startTime":"0","endTime":"0","summary":"Darlene Noci, Chief Development Officer of Nuvalent Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvalent Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 02, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDLgLJJm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Nuvalent Chief Development Officer Darlene Noci Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","NUVL"],"gpt_icon":0},{"id":"2586529834","title":"Nuvalent Director Matthew Shair Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586529834","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586529834?lang=en_us&edition=fundamental","pubTime":"2025-11-27 05:31","pubTimestamp":1764192673,"startTime":"0","endTime":"0","summary":"Matthew Shair, Director of Nuvalent Inc., reported a disposal of common shares of Nuvalent Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvalent Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 26, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDL4h6B9c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Nuvalent Director Matthew Shair Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","NUVL"],"gpt_icon":0},{"id":"2586143564","title":"Director James E. Flynn Reports Sale of Nuvalent Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586143564","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586143564?lang=en_us&edition=fundamental","pubTime":"2025-11-25 09:01","pubTimestamp":1764032498,"startTime":"0","endTime":"0","summary":"James E. Flynn, Director by Deputization, and Deerfield Management Company, L.P. reported the disposal of common shares of Nuvalent Inc. Other reporting beneficial owners are also included in the filing. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvalent Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 24, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDLb9LSMZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Director James E. Flynn Reports Sale of Nuvalent Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","NUVL"],"gpt_icon":0},{"id":"2586941865","title":"Nuvalent Closes Public Offering of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586941865","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586941865?lang=en_us&edition=fundamental","pubTime":"2025-11-25 05:41","pubTimestamp":1764020466,"startTime":"0","endTime":"0","summary":"Nuvalent  said late Monday it closed a public offering of nearly 5 million class A common shares at $101 apiece for gross proceeds of around $500 million.The offering comprised the full exercise of an overallotment option by underwriters to buy an additional 742,574 shares from the selling stockholders, the company said.The company did not receive any proceeds from the sale of additional shares, according to a statement.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","BK4139","NUVL"],"gpt_icon":0},{"id":"2585846493","title":"Nuvalent initiated with a Buy at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2585846493","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585846493?lang=en_us&edition=fundamental","pubTime":"2025-11-24 20:31","pubTimestamp":1763987463,"startTime":"0","endTime":"0","summary":"Truist initiated coverage of Nuvalent (NUVL) with a Buy rating and $140 price target Nuvalent is emerging as a disruptive precision oncology compan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nuvalent-initiated-with-a-buy-at-truist-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nuvalent-initiated-with-a-buy-at-truist-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","NUVL"],"gpt_icon":0},{"id":"2585611075","title":"J.P. Morgan Sticks to Its Buy Rating for Nuvalent (NUVL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2585611075","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585611075?lang=en_us&edition=fundamental","pubTime":"2025-11-21 20:18","pubTimestamp":1763727497,"startTime":"0","endTime":"0","summary":"In a report released on November 19, Anupam Rama from J.P. Morgan maintained a Buy rating on Nuvalent, with a price target of $147.00. The company’...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-sticks-to-its-buy-rating-for-nuvalent-nuvl-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-sticks-to-its-buy-rating-for-nuvalent-nuvl-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NUVL"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":3,"totalSize":137,"code":"91000000","status":"200"}]}}